Nearly
one million people die each year from lung cancer and the World Health
Organization expects that the mortality rate will continue to grow as
more and more people begin to smoke. However, the researchers were able to make an important step in the fight against this disease and save lives.
That smoking is the cause of most cases of lung cancer and experts have long established the connection. Besides found that inhalation of toxins people located near the smoker may also cause disease.
Nearly 1 million people die from lung cancer each year. Another 600,000 die from the so-called passive smoking. And until recently, treatment for most patients was reduced to chemotherapy. Sometimes this treatment works, but not very often makes chemotherapy. Researchers at the Cancer Center Memorial Sloan Kettering tried to come up with the best treatment option that can help reduce swelling, without affecting healthy tissue and relieve patients from the negative side effects associated with chemotherapy.
The new treatment is based on the tests, allowing to determine the damaged genes, called oncogenes that allow cancer cells to grow and spread. Oncologist Mark Kris of Memorial Sloan Kettering conducted a study that examined the role of oncogenes in the spread of cancer. In a study of Chris attended more than 1,000 patients who were diagnosed with lung cancer. During the experiment, experts analyzed the tumor in 10 different mutations that lead to the spread of disease.
"We were able to test 10 different oncogenes, which are the basis of lung cancer. We were able to identify one of the oncogenes, which causes lung cancer in 64 percent of patients, "- said Mark Kris.
Identifying these damaged genes allow doctors to choose the best treatment direction. Dr. Chris said that such a test is a rapid, accurate and cost-effective. Furthermore, drugs aimed at suppressing damaged genes cause fewer side effects than conventional chemotherapy. Chris also explained that the results of the study will help treat people with all types of cancer, and doctors will be able to learn more about the genes that control this terrible disease.
That smoking is the cause of most cases of lung cancer and experts have long established the connection. Besides found that inhalation of toxins people located near the smoker may also cause disease.
Nearly 1 million people die from lung cancer each year. Another 600,000 die from the so-called passive smoking. And until recently, treatment for most patients was reduced to chemotherapy. Sometimes this treatment works, but not very often makes chemotherapy. Researchers at the Cancer Center Memorial Sloan Kettering tried to come up with the best treatment option that can help reduce swelling, without affecting healthy tissue and relieve patients from the negative side effects associated with chemotherapy.
The new treatment is based on the tests, allowing to determine the damaged genes, called oncogenes that allow cancer cells to grow and spread. Oncologist Mark Kris of Memorial Sloan Kettering conducted a study that examined the role of oncogenes in the spread of cancer. In a study of Chris attended more than 1,000 patients who were diagnosed with lung cancer. During the experiment, experts analyzed the tumor in 10 different mutations that lead to the spread of disease.
"We were able to test 10 different oncogenes, which are the basis of lung cancer. We were able to identify one of the oncogenes, which causes lung cancer in 64 percent of patients, "- said Mark Kris.
Identifying these damaged genes allow doctors to choose the best treatment direction. Dr. Chris said that such a test is a rapid, accurate and cost-effective. Furthermore, drugs aimed at suppressing damaged genes cause fewer side effects than conventional chemotherapy. Chris also explained that the results of the study will help treat people with all types of cancer, and doctors will be able to learn more about the genes that control this terrible disease.
0 comments:
Post a Comment